These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 6833337)
1. The effect of thrombocytopenia and antiserotonin treatment on the lodgement of circulating tumor cells. A vital fluorescence microscopic, electron microscopic and isotope study in the rat. Skolnik G; Ericson LE; Bagge U J Cancer Res Clin Oncol; 1983; 105(1):30-7. PubMed ID: 6833337 [TBL] [Abstract][Full Text] [Related]
2. The influence of antiserotonin treatment with ketanserin on the pulmonary lodgement of circulating tumour cells in normal and traumatized rats. Skolnik G; Ivarsson L; Bagge U Eur J Cancer Clin Oncol; 1983 Jun; 19(6):843-6. PubMed ID: 6683651 [TBL] [Abstract][Full Text] [Related]
3. The importance of 5-HT for tumor cell lodgement in the liver. Skolnik G; Bagge U; Dahlström A; Ahlman H Int J Cancer; 1984 Apr; 33(4):519-23. PubMed ID: 6368410 [TBL] [Abstract][Full Text] [Related]
4. The arrest of circulating tumor cells in the liver microcirculation. A vital fluorescence microscopic, electron microscopic and isotope study in the rat. Bagge U; Skolnik G; Ericson LE J Cancer Res Clin Oncol; 1983; 105(2):134-40. PubMed ID: 6826636 [TBL] [Abstract][Full Text] [Related]
6. The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver. Skolnik G; Bagge U; Blomqvist G; Djärv L; Ahlman H Clin Exp Metastasis; 1989; 7(2):169-74. PubMed ID: 2537694 [TBL] [Abstract][Full Text] [Related]
7. Studies on mechanisms involved in metastasis formation from circulating tumor cells. Factors influencing tumor cell lodgement during normal and post-traumatic conditions. Skolnik G; Alpsten M; Ivarsson L J Cancer Res Clin Oncol; 1980; 97(3):249-56. PubMed ID: 7440626 [TBL] [Abstract][Full Text] [Related]
8. Differences in lodgement of tumour cells in muscle and liver. Blomqvist G; Skolnik G; Braide M; Bjursten LM; Blixt A; Bagge U Clin Exp Metastasis; 1988; 6(4):285-9. PubMed ID: 3359711 [TBL] [Abstract][Full Text] [Related]
9. The influence of trauma, Dextran 1000, and Dextran 40 on the lodgement of circulating tumor cells. Skolnik G; Alpsten M; Ivarsson L J Cancer Res Clin Oncol; 1980; 97(3):241-8. PubMed ID: 6160158 [TBL] [Abstract][Full Text] [Related]
10. Ketanserin alters [3H]serotonin uptake and release in rat hypothalamus. Offord SJ; Warwick RO Eur J Pharmacol; 1984 Sep; 104(3-4):379-82. PubMed ID: 6499929 [TBL] [Abstract][Full Text] [Related]
11. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure. Grobecker H; Gessler I; Delius W; Dominiak P; Kees F J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024 [TBL] [Abstract][Full Text] [Related]
12. Comparative effects of ketanserin, a novel serotonergic receptor antagonist, on 5HT-induced shape change and 5HT uptake in rat and human platelets. Lampugnani MG; de Gaetano G Biochem Pharmacol; 1982 Sep; 31(18):3000-2. PubMed ID: 7138588 [No Abstract] [Full Text] [Related]
13. A comparison between morphological, rheological and lodgement properties of rat fibrosarcoma cells harvested from solid tumours and cultures. Nannmark U; Johansson BR; Bagge U Clin Exp Metastasis; 1991; 9(2):119-26. PubMed ID: 2032417 [TBL] [Abstract][Full Text] [Related]
14. The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin. Ahlman H; Dahlström A; Grönstad K; Tisell LE; Oberg K; Zinner MJ; Jaffe BM Ann Surg; 1985 Jan; 201(1):81-6. PubMed ID: 2578277 [TBL] [Abstract][Full Text] [Related]
15. Selective inhibition by ketanserin and spiroperidol of 5-HT-induced myometrial contraction. Ichida S; Hayashi T; Terao M Eur J Pharmacol; 1983 Dec; 96(1-2):155-8. PubMed ID: 6662193 [TBL] [Abstract][Full Text] [Related]
16. Influence of ketanserin on 5-hydroxytryptamine-induced cerebrovascular spasm in the cat. Vällfors B; Dahlström A; Boström S; Ahlman H J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S60-3. PubMed ID: 2412061 [TBL] [Abstract][Full Text] [Related]
17. Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery. Inhibition by the S2 receptor antagonist ketanserin. Verheyen A; Vlaminckx E; Lauwers F; Van Den Broeck C; Wouters L Arch Int Pharmacodyn Ther; 1984 Aug; 270(2):280-98. PubMed ID: 6486974 [TBL] [Abstract][Full Text] [Related]
18. The specificity of ketanserin in the inhibition of serotonin-induced steroidogenesis in the rat adrenal zona glomerulosa. Williams BC; Shaikh S; Edwards CR J Hypertens Suppl; 1984 Dec; 2(3):S559-61. PubMed ID: 6100754 [TBL] [Abstract][Full Text] [Related]
19. Lack of a difference between ketanserin and ritanserin in central vs. peripheral serotonin receptor antagonism. Cohen ML; Bloomquist WL; Snoddy HD; Fuller RW Life Sci; 1989; 45(13):1185-9. PubMed ID: 2507847 [TBL] [Abstract][Full Text] [Related]
20. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation. McLennan PL; Taylor DA Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]